Stock Code: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022023 bond Code: 128026 bond abbreviation: Zhongxing convertible bonds
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Summary of 2021 Annual Report
1、 Important tips
The summary of this annual report comes from the full text of the annual report. In order to fully understand the company’s operating results, financial status and future development plan, investors should carefully read the full text of the annual report in the media designated by the CSRC.
In addition to the following directors, other directors attended the meeting of the board of directors to consider the annual report in person
Name of director not present in person position of director not present in person reason for not attending the meeting name of the entrusted person
Tips on non-standard audit opinions □ applicable √ not applicable to the profit distribution plan of common shares or the plan of converting accumulation fund into share capital in the reporting period considered by the board of directors √ applicable □ not applicable whether to convert accumulation fund into share capital □ yes √ no
The company’s profit distribution plan for ordinary shares reviewed and approved by the board of directors is: when the profit distribution plan for 2021 is implemented, the total share capital on the date of equity registration (deducting the repurchased shares in the special repurchase account) is taken as the base, and the cash dividend of 1.00 yuan (including tax) is distributed to all shareholders for every 10 shares, 0 bonus shares (including tax) are given, and the accumulation fund is not converted into share capital. Preferred stock profit distribution plan for the reporting period adopted by the board of directors □ applicable √ not applicable II. Basic information of the company 1. Company profile
Stock abbreviation Tianshui Zhongxing Bio-Technology Co.Ltd(002772) stock code Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Listed on Shenzhen Stock Exchange
Contact person and contact information secretary of the board of directors securities affairs representative
Name: Qian Xiaoli Qian Xiaoli
Office address: National Agricultural Science and Technology Park, Maiji District, Tianshui City, Gansu Province
Fax: 09382855051
Tel: 09382851611
E-mail [email protected]. [email protected].
2. Introduction to main business or products during the reporting period
(I) main business
The company is a modern agricultural enterprise specializing in the R & D, industrialized cultivation and sales of edible fungi. Adhering to the mission of “fungi benefit health and make fungi serve mankind”, relying on modern biotechnology and taking safe production as the guarantee, we are committed to providing consumers with green, safe and high-quality edible fungi products; At present, edible fungus production bases have been established in Gansu, Shaanxi, Shandong, Jiangsu, Henan, Jilin, Sichuan, Anhui, Hubei and other places. The main business scope of the company is the production and sales of edible fungi, medicinal fungi and their accessories, the R & D, application, research and promotion of microbial technology, bioengineering technology and new agricultural technology, and the production, processing and sales of agricultural and sideline local products. (II) main products and uses
During the reporting period, the company’s main products were Flammulina velutipes and Agaricus bisporus fresh products.
1. Flammulina velutipes
Flammulina velutipes is a fungus belonging to the genus Flammulina in the family tricholomidae. Its scientific name is Trichoderma, also known as Flammulina velutipes, Pleurotus ostreatus, Pleurotus ostreatus, etc. it is named for its slender stalk, which looks like Flammulina velutipes. It ejects countless basidiospores from mature fruiting bodies, and the basidiospores germinate to form hyphae. Under appropriate conditions, the hyphae develop to a certain stage and differentiate into fruiting bodies. After the fruiting bodies mature, a large number of basidiospores are scattered. It is a fungus that likes low temperature, The suitable temperature for the growth and development of fruiting body is 8-13 ℃, and its whole growth is spent in low temperature; Flammulina velutipes is widely distributed in nature, including China, Japan, Russia, Europe, North America and Australia. In China, it grows from Heilongjiang in the north, Yunnan in the south, Jiangsu in the East and Xinjiang in the West; Flammulina velutipes does not contain chlorophyll and has no photosynthesis. It absorbs organic matter from the culture medium under artificial cultivation; Flammulina velutipes is famous for its smooth cover, crisp handle, rich nutrition and delicious taste, especially the best ingredients of cold dishes and hot pot.
2. Agaricus bisporus
Agaricus bisporus and Agaricus bisporus are grass rot fungi, also known as white mushroom, mushroom and foreign mushroom. Agaricus bisporus is a mushroom cultivated and consumed worldwide, “World mushroom” “In addition to fresh food, canned food and condiments, mycelium can also be used to produce protein, oxalic acid, mushroom sugar and other substances. According to Baidu Encyclopedia, Agaricus bisporus has both edible and medicinal value. ① edible value: thick meat, delicious taste, low heat energy and good medical and health care effect; Agaricus bisporus fruiting body has the characteristics of high protein and low fat, and is rich in polysaccharides, mineral elements and nuclear elements Glycosidic acid, crude fiber and superoxide dismutase; The protein content of fruiting body of Agaricus bisporus is high, the crude protein content is close to 40%, but the fat content is only 1.5%. In terms of protein amino acid composition, it contains 17 kinds of amino acids, with an amino acid content of 19.55%, including 8 kinds of human essential amino acids, accounting for 42.30% of the total amino acids. Both indicators meet the requirements of ideal egg white quality put forward by FAO and who. ② Medicinal value: Traditional Chinese medicine believes that Agaricus bisporus is cool and sweet in nature. It has the functions of strengthening the spleen and appetizing, regulating qi and resolving phlegm. It can be used as an auxiliary treatment for diseases such as less body deficiency, more phlegm, abdominal distention, nausea and diarrhea; It is recorded in compendium of Materia Medica that Agaricus bisporus can benefit intestines and stomach, reduce phlegm and regulate qi. Agaricus bisporus contains tyrosinase, trypsin, maltase and so on. It helps digestion, can dissolve certain cholesterol, and also has the effect of lowering blood pressure. It has a good adjuvant effect on many diseases such as hypertension, hyperlipidemia, diabetes and so on. Some countries have also found broad-spectrum antibiotics containing anti-cancer substances and anti bacteria; In addition, Agaricus bisporus has the function of anti-oxidation and enhancing immune function, which can be developed and used as an immune function regulator; Agaricus bisporus also plays an auxiliary role in the treatment of leukopenia, digestive tract disorders and other diseases.
(III) industry development and changes and market competition pattern
With the economic development and consumption upgrading, the deepening of the concept of green and healthy consumption and the rapid development of the deep processing industry of edible fungi, the market demand of edible fungi has increased rapidly year by year, and the prospect of the industry is good; Compared with developed countries, the proportion of industrialized edible fungi in China is relatively low, which has a lot of room for rise; Based on the above reasons, we are optimistic about the prospect of the industry. In recent years, the industrialized production of edible fungi has expanded rapidly, and the competition in the edible fungi industry has intensified as a whole, but the production capacity has continued to expand rapidly, while the growth of market demand can not digest the increase in supply brought by the new production capacity, and the sales price of edible fungi fluctuates to a certain extent; At the same time, affected by technical bottlenecks, competition pattern, sales price, circulation channels and enterprise management, the overall ex factory price of products is low; How to adjust production capacity, improve product quality and maintain the stability of gross profit margin has become the main challenge for enterprises to develop edible fungus business. During the reporting period, the profitability of the whole industry tended to be low due to the impact of product prices and raw material costs.
(IV) industry position of the company
The company is a “national key leading enterprise in agricultural industrialization”. At the end of the reporting period, the daily production capacity of edible fungi of the company is 1105 tons, with obvious scale advantages. In particular, the variety of Agaricus bisporus, known as “world mushroom”, has occupied the leading position in the world and is becoming a new profit growth point of the company. At present, the company has arranged 7 standardized Agaricus bisporus production lines (6 of which have been put into operation), integrating the separate mode of European composting plant and mushroom breeding plant into a standardized whole through design and improvement, and catching up with the industrial planting technology of Agaricus bisporus which has been ahead of China for many years in less than 10 years. The company has established edible fungus production bases in Gansu, Shaanxi, Shandong, Jiangsu, Henan, Jilin, Sichuan, Anhui, Hubei and other places, and its products can cover the main markets in the country. 3. Main accounting data and financial indicators (1) whether the company needs to retroactively adjust or restate the accounting data of previous years in recent three years □ yes √ no
Unit: Yuan
By the end of 2021, by the end of 2020, by the end of 2019 compared with the end of last year
reduce
Total assets 655129720204558194418622 17.37% 501291561136
Net assets attributable to shareholders of listed companies 324860012487272910552777 19.04% 259948213226
20212020 year-on-year increase or decrease 2019
Operating income 155614672549148317849171 4.92% 115583246049
Net profit attributable to shareholders of listed company 549680051018895929302 – 70.91% 6840383718
Net profit attributable to shareholders of listed companies after deducting non recurring profit and loss of 308632037814727832294 – 79.04% 3797588767
Net cash flow from operating activities -4136812099038931879726 – 206.26% 35914993219
Basic earnings per share (yuan / share) 0.14 0.56 – 75.00% 0.19
Diluted earnings per share (yuan / share) 0.14 0.56 – 75.00% 0.19
Weighted average return on net assets: 1.90%, 7.07% – 5.17%, 2.58%
(2) Main accounting data by quarter
Unit: Yuan
First quarter second quarter third quarter fourth quarter
Operating income 39577282020308586126123547402259149704755326
Net profit attributable to shareholders of listed companies 4342496207 -3089346670 -615359721810397248191
Net profit attributable to shareholders of listed companies after deducting non recurring profits and losses of 3018282836 -4540754370 -3 China Railway Prefabricated Construction Co.Ltd(300374) 5357909166447
Net cash flow from operating activities 9679008405 -28814508190 -15729538597 -6503082608
Whether the above financial indicators or their total amount are significantly different from the financial indicators related to the quarterly report and semi annual report disclosed by the company □ yes √ No 4. Share capital and shareholders (1) advantages of common shareholders and restoration of voting rights
